Fusion Pharmaceuticals Inc. (FUSN) Stock Analysis
DELISTED 2024
What happened to Fusion Pharmaceuticals Inc. (FUSN) stock?
Fusion Pharmaceuticals Inc. (FUSN) no longer trades on public markets. It was delisted in June 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- June 2024
- Last recorded price (historical):
- $21.55 (last quote on record before the June 2024 delisting; historical, not a current quote)
Market cap $1.83B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Fusion Pharmaceuticals Inc. (FUSN). Fusion Pharmaceuticals Inc. is a clinical-stage oncology company focused on developing radiopharmaceuticals as precision medicines. Their lead product candidate, FPI-1434, is in Phase 1 clinical trials for solid tumors.
Last analyzed: Mar 18, 2026Fusion Pharmaceuticals Inc. (FUSN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy FUSN shares?
No. FUSN stopped trading on public markets in June 2024, so the shares are not available through a broker. Anything you see quoted for FUSN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before FUSN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Fusion Pharmaceuticals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.